drugset / Trial / NCT00676897

Statin Therapy in the Treatment of Sepsis

NCT00676897

Phase 2/3 Completed 18 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Simvastatin will attenutat IL-6 levels and lead to a more rapid shock reversal than placebo

Timeline

Start
2008-02
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg Oral